CN Stock MarketDetailed Quotes
300878 Zhejiang Wecome Pharmaceutical
- 19.90
- -0.67-3.26%
Market Closed Dec 13 15:00 CST
2.88BMarket Cap-86.52P/E (TTM)
20.48High19.77Low47.39KlotVolume20.20Open20.57Pre Close95.07MTurnover3.29%Turnover RatioLossP/E (Static)144.79MShares26.1352wk High2.14P/B2.87BFloat Cap13.3152wk Low24.68Limit Up144.12MShs Float59.90Historical High16.46Limit Down3.45%Amplitude13.31Historical Low0.25Dividend TTM20.06Avg Price26.63KlotAsk1.26%Div YieldTTM100Lot Size18.30KlotBid
Zhejiang Wecome Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.57%345.5M | -14.40%243.36M | -5.27%127.57M | -4.21%544.43M | -10.87%386.34M | -0.00%284.28M | -15.46%134.66M | -5.02%568.37M | 4.25%433.47M | 5.45%284.28M |
| Refunds of taxes and levies | ---- | ---- | --6.21M | ---- | -54.32%150.92K | 216.14%150.92K | ---- | ---- | --330.39K | --47.74K |
| Cash received relating to other operating activities | 58.09%20.7M | 0.11%9.09M | 72.12%6.87M | -21.74%27.67M | -52.10%13.1M | -47.28%9.08M | 45.51%3.99M | 77.75%35.36M | -5.58%27.34M | -9.02%17.22M |
| Cash inflows from operating activities | -8.36%366.2M | -13.99%252.44M | 1.44%140.65M | -5.24%572.1M | -13.35%399.59M | -2.67%293.51M | -14.43%138.65M | -2.36%603.73M | 3.68%461.14M | 4.51%301.55M |
| Goods services cash paid | -8.50%129.48M | 0.23%95.05M | -12.64%42.98M | 60.25%223.83M | 6.33%141.51M | 3.71%94.83M | -10.64%49.2M | -46.19%139.68M | -14.24%133.08M | -8.25%91.44M |
| Staff behalf paid | 21.48%101.21M | 14.12%64.45M | 49.33%45.75M | 5.27%109.5M | -0.02%83.31M | 2.04%56.48M | 11.11%30.64M | 6.59%104.02M | 5.14%83.32M | 1.82%55.35M |
| All taxes paid | -8.19%35.46M | 14.33%18.88M | 93.52%13.94M | 22.55%34.29M | 39.24%38.62M | -24.55%16.51M | -54.22%7.21M | -59.58%27.98M | -45.63%27.74M | -25.90%21.89M |
| Cash paid relating to other operating activities | 23.92%135.28M | 20.82%93.95M | 42.74%54.41M | -21.77%146.19M | -31.77%109.17M | -25.80%77.76M | -46.62%38.12M | -28.03%186.88M | -33.26%159.99M | -37.16%104.79M |
| Cash outflows from operating activities | 7.74%401.43M | 10.89%272.33M | 25.51%157.09M | 12.05%513.81M | -7.80%372.61M | -10.20%245.58M | -26.28%125.17M | -33.16%458.56M | -23.05%404.13M | -21.94%273.47M |
| Net cash flows from operating activities | -230.56%-35.23M | -141.50%-19.89M | -221.89%-16.44M | -59.85%58.29M | -52.67%26.98M | 70.68%47.93M | 273.94%13.49M | 314.30%145.18M | 170.88%57.01M | 145.44%28.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 10,830.86%241M | 10,830.86%241M | --10M | -88.89%2.2M | -87.59%2.2M | -80.22%2.2M | ---- | --19.84M | 26.85%17.76M | --11.14M |
| Cash received from returns on investments | --6.76M | --6.76M | ---- | ---- | ---- | ---- | ---- | ---- | --2.08M | --2.08M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 35,625.81%4.39M | 1,071.20%143.82K | ---30.53K | -92.78%23.35K | -85.48%12.28K | -82.89%12.28K | ---- | 40.33%323.66K | -50.24%84.59K | --71.79K |
| Net cash received from disposal of subsidiaries and other business units | --50.7M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | -96.96%7.59M | -96.96%7.59M | --241M | 606.48%399.16M | --250.03M | --250.03M | ---- | --56.5M | ---- | ---- |
| Cash inflows from investing activities | 23.07%310.43M | 1.29%255.49M | --250.97M | 423.55%401.39M | 1,165.81%252.24M | 1,796.52%252.24M | ---- | 450.74%76.67M | 40.63%19.93M | --13.3M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -21.27%96.84M | -31.43%62.62M | -24.55%37.41M | -19.67%139.29M | -32.99%123M | -22.25%91.32M | -35.17%49.58M | 1.34%173.39M | 33.63%183.56M | 53.23%117.45M |
| Cash paid to acquire investments | ---- | ---- | --60M | 871.08%242.77M | ---- | ---- | ---- | 760.53%25M | -71.44%9.97M | --8.13M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.66%9.79M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -96.78%10.02M | 133.98%241.58M | --581.04K | --581.04K | --310.91M | --103.25M | ---- |
| Cash outflows from investing activities | -73.44%96.84M | -31.86%62.62M | 94.20%97.41M | -24.47%392.07M | 22.84%364.58M | -26.82%91.9M | -40.72%50.16M | 151.66%519.1M | 72.27%296.78M | 63.85%125.58M |
| Net cash flows from investing activities | 290.15%213.6M | 20.29%192.87M | 406.15%153.56M | 102.11%9.31M | 59.42%-112.33M | 242.80%160.35M | 35.69%-50.16M | -130.01%-442.43M | -75.10%-276.85M | -46.49%-112.28M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --3M | --3M | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --3M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -48.17%181.26M | 48.91%181.26M | -75.05%22.01M | 30.55%377.04M | 337.15%349.72M | 143.44%121.72M | --88.24M | 477.61%288.81M | 60.00%80M | --50M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200K | --145.48M | ---- |
| Cash inflows from financing activities | -48.61%181.26M | 48.91%181.26M | -75.05%22.01M | 31.50%380.04M | 56.43%352.72M | 143.44%121.72M | --88.24M | 419.09%289.01M | 325.43%225.48M | 1,566.67%50M |
| Borrowing repayment | 13.91%262M | 423.68%261.84M | --261.85M | 409.80%260M | 360.00%230M | --50M | ---- | 246.94%51M | 240.14%50M | ---- |
| Dividend interest payment | 932.69%41.54M | 1,665.08%40.69M | -6.70%1.29M | -83.68%7.47M | -90.66%4.02M | -94.59%2.31M | 177.05%1.39M | -43.52%45.74M | -43.21%43.07M | -43.85%42.59M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --450K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | --59.2M | --59.2M | ---- | 10.90%15M | ---- | ---- | ---- | -3.07%13.52M | ---- | ---- |
| Cash outflows from financing activities | 55.00%362.74M | 591.57%361.73M | 18,895.87%263.14M | 156.17%282.46M | 151.46%234.02M | 22.82%52.31M | 177.05%1.39M | 0.57%110.27M | 2.79%93.07M | -52.97%42.59M |
| Net cash flows from financing activities | -252.90%-181.48M | -359.97%-180.46M | -377.62%-241.13M | -45.41%97.57M | -10.36%118.7M | 836.26%69.42M | 17,471.05%86.86M | 431.23%178.74M | 452.71%132.41M | 108.47%7.41M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -109.33%-3.11M | -102.69%-7.48M | -307.26%-104.01M | 239.38%165.17M | 138.14%33.35M | 461.62%277.69M | 158.18%50.18M | 62.26%-118.51M | 68.33%-87.43M | 66.02%-76.79M |
| Add:Begin period cash and cash equivalents | 102.33%326.58M | 102.33%326.58M | 104.41%329.93M | -42.34%161.41M | -42.34%161.41M | -42.34%161.41M | -42.34%161.41M | -52.87%279.92M | -52.87%279.92M | -52.87%279.92M |
| End period cash equivalent | 66.09%323.47M | -27.33%319.1M | 6.77%225.92M | 102.33%326.58M | 1.18%194.75M | 116.17%439.1M | 9.26%211.59M | -42.34%161.41M | -39.45%192.49M | -44.80%203.13M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Reservations with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
